CAR/TCR T cell manufacturing and in vitro assay

Immunotherapy has emerged as one of the most promising approaches for the treatment of cancer. Unlike traditional cancer treatments, immunotherapy harnesses the natural power of your immune system to fight the cancer. Genetically modifying T cells with Chimeric Antigen Receptors (CARs) or TCR is the most pursued approach to generate tumor-specific T cells. CAR/TCR  T cells targeting tumor-associated antigens can be infused into patients to attack the tumor. 

We offer service including lentivirus production, CAR/TCR T cell manufacturing, cell banking, in vitro cell-based assay (phenotype analysis, apoptosis, cytokine secretion, cytotoxicity, etc ) and NSG mice testing. Please contact info@goldenbridgen.com for Quote.